Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $62
DexCom Reaches a Multi-year Low as Downgrades Follow Guidance Cut
BMO Capital Trims Franklin Resources' Price Target to $26 From $27
Cantor Fitzgerald Raises Price Target on Bristol-Myers Squibb to $50 From $45
JPMorgan Adjusts Consolidated Edison's Price Target to $96 From $90
T. Rowe Price Gr Analyst Ratings
Morgan Stanley Maintains Consolidated Edison(ED.US) With Sell Rating, Cuts Target Price to $75
Consolidated Edison (ED) Receives a Sell From Morgan Stanley
Duke Energy (DUK) Receives a Hold From Morgan Stanley
Insider Trading: Best Buy's Founder Sells Stock Worth $88M
Morgan Stanley Adjusts Price Target on Duke Energy to $99 From $98, Maintains Equalweight Rating
Morgan Stanley Trims Price Target on Consolidated Edison to $75 From $76, Maintains Underweight Rating
Hold Rating on Bristol-Myers Squibb Amid Mixed Performance and Evolving Pipeline
Deutsche Numis Initiates Bristol-Myers Squibb(BMY.US) With Hold Rating, Announces Target Price $45
Duke Energy Price Target Raised to $114.00/Share From $112.00 by Keybanc
Duke Energy Analyst Ratings
Bristol-Myers Squibb Analyst Ratings
Baird Adjusts Price Target on Stanley Black & Decker to $80 From $78
Morgan Stanley Adjusts Franklin Resources' Price Target to $22 From $24, Maintains Underweight Rating
J.P. Morgan Keeps Their Hold Rating on Franklin Resources (BEN)